ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Pharmacyclics, Inc. 

995 East Arques Avenue

Sunnyvale  California  94086  U.S.A.
Phone: 408-774-0330 Fax: 408-774-0340


SEARCH JOBS








 Company News
Lucky Drug Made Pharmacyclics, Inc. (PCYC)' Robert Duggan A Billionaire—Can He Do It Again? 4/16/2014 8:24:34 AM    More...
Pharmacyclics, Inc. (PCYC) Files Supplemental New Drug Application For IMBRUVICA With Phase III CLL Study Data 4/8/2014 9:25:10 AM    More...
Pharmacyclics, Inc. (PCYC) Reports Fourth Quarter And Full Year 2013 Results 2/21/2014 6:18:17 AM    More...
Pharmacyclics, Inc. (PCYC) Announces Date Of Conference Call To Discuss Financial Results For Fourth Quarter And Year End 2013 2/17/2014 6:02:45 AM    More...
Pharmacyclics, Inc. (PCYC)'s Imbruvica Wins Second Cancer Approval 2/13/2014 6:58:32 AM    More...
Pharmacyclics, Inc. (PCYC) Release: Independent Data Monitoring Committee Recommends Phase III Study Of IMBRUVICA™ (Ibrutinib) Versus Ofatumumab Be Stopped Early Based On Statistically Significant Improvement In Progression Free Survival And Overall Survival 1/7/2014 10:59:54 AM    More...
Pharmacyclics, Inc. (PCYC) Announces Data Presentations For Ibrutinib In B-Cell Malignancies 12/11/2013 8:54:09 AM    More...
Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC)'s Closely Watched Leukemia Drug Effective In Long Term Study 12/9/2013 6:43:06 AM    More...
Pharmacyclics, Inc. (PCYC) Snags $50 Million As Cancer Drug Moves Toward European Approval 11/21/2013 8:06:49 AM    More...
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013 11:41:20 AM    More...
12345678910...